Imunon
Clinical trials sponsored by Imunon, explained in plain language.
-
New combo aims to wipe out hidden ovarian cancer cells
Disease control Recruiting nowThis study tests whether adding an experimental drug (IMNN-001) to standard chemotherapy and bevacizumab can better eliminate tiny leftover cancer in people with newly diagnosed advanced ovarian, fallopian tube, or peritoneal cancer. About 30 participants will be randomly assigne…
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for ovarian cancer: experimental drug combo enters final testing phase
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug IMNN-001 to standard chemotherapy helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer. About 500 newly diagnosed adults will receive either the drug combination or chemotherapy …
Phase: PHASE3 • Sponsor: Imunon • Aim: Disease control
Last updated May 20, 2026 11:55 UTC